Table 3. Reduced expression of ZNF545 in breast cancer.
Dataset | Tissue type | Sample number | Median of expression intensity (log 2) | Fold change | p-value (normal vs cancer) |
TCGA Breast | Breast | 61 | 0.463 | ||
ICBC | 3 | −0.368 | −1.835 | 0.002 | |
MBC | 3 | 0.064 | −1.259 | 0.007 | |
IC | 76 | 0.150 | −1.264 | 1.14E-05 | |
IDC | 389 | 0.167 | −1.329 | 2.87E-09 | |
ILC | 36 | 0.275 | −1.230 | 0.014 | |
Zhao breast | Breast | 3 | 0.480 | ||
LC | 19 | −0.180 | −1.482 | 2.30E-04 | |
IDC | 38 | 0.145 | −1.196 | 3.49E-04 | |
Karnoub breast | Breast | 15 | −0.385 | ||
ILC | 7 | −0.797 | −1.475 | 0.006 | |
Finak breast | Breast | 6 | −0.105 | ||
IC | 53 | −2.768 | −5.909 | 6.26E-13 |
Data extracted from cancer microdatabase Oncomine: https://www.oncomine.org/. ICBC: Intraductal Cribriform Breast Adenocarcinoma; MBC: Male Breast Carcinoma; IC: Invasive Breast Carcinoma; IDC: invasive ductal breast carcinoma; ILC: invasive lobular breast carcinoma; LC: lobular breast carcinoma.